Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6343512 | 0.83 | L3MBTL1 (0.38) | L3MBTL1SMN1; SMN2ALDH1A1NPSR1GAA | |
| SCHEMBL10535054 | 0.79 | SMN1; SMN2 (0.45) | L3MBTL1SMN1; SMN2ALDH1A1NPSR1GAA | |
| SCHEMBL411806 | 0.77 | SMN1; SMN2 (0.42) | L3MBTL1SMN1; SMN2ALDH1A1GAAMAPK1 | |
| SCHEMBL546205 | 0.77 | L3MBTL1 (0.41) | L3MBTL1SMN1; SMN2ALDH1A1NPSR1GAA | |
| SCHEMBL6925024 | 0.76 | SMN1; SMN2 (0.41) | L3MBTL1SMN1; SMN2ALDH1A1GAAMAPK1 | |
| SCHEMBL13858310 | 0.76 | SMN1; SMN2 (0.41) | L3MBTL1SMN1; SMN2ALDH1A1GAAMAPK1 | |
| SCHEMBL7056761 | 0.76 | ALOX5 (0.35) | SMN1; SMN2ALDH1A1 | |
| SCHEMBL6925032 | 0.76 | SMN1; SMN2 (0.41) | L3MBTL1SMN1; SMN2ALDH1A1GAAMAPK1 | |
| SCHEMBL6925027 | 0.76 | SMN1; SMN2 (0.41) | L3MBTL1SMN1; SMN2ALDH1A1GAAMAPK1 | |
| SCHEMBL23130401 | 0.74 | SMN1; SMN2 (0.40) | L3MBTL1SMN1; SMN2ALDH1A1NPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6410486-B2 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-25 | — | — | US | disclosed |
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | WETTERICH FRANK (DE) | 2002-02-14 | — | — | US | disclosed |
| US-6265447-B1 | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-0970044-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2000-01-12 | — | — | EP | disclosed |
| WO-1998041499-A1 | CYCLOALKYLALKANECARBOXAMIDES AND THE PRODUCTION AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 1998-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019422-A1 | Cycloalkylalkanecarboxamides and their preparation and use | CBR3, CYCS, CBR1 | L3MBTL1 2632/4885SMN1; SMN2 4443/4885ALDH1A1 433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.